1. Home
  2. KALA vs XXII Comparison

KALA vs XXII Comparison

Compare KALA & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.56

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$0.77

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALA
XXII
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
6.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
KALA
XXII
Price
$0.56
$0.77
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$31.50
N/A
AVG Volume (30 Days)
20.4M
160.7K
Earning Date
11-19-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$20,346,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$79.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.98
52 Week Low
$0.51
$0.78
52 Week High
$20.60
$287.27

Technical Indicators

Market Signals
Indicator
KALA
XXII
Relative Strength Index (RSI) 37.14 31.29
Support Level $0.57 $0.90
Resistance Level $0.72 $0.88
Average True Range (ATR) 0.08 0.07
MACD 0.04 -0.01
Stochastic Oscillator 20.52 2.55

Price Performance

Historical Comparison
KALA
XXII

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: